Other
Polycystic Kidney Disease Foundation
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
1 recruiting2 with results
Enrollment Performance
Analytics
Phase 3
2(66.7%)
N/A
1(33.3%)
3Total
Phase 3(2)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04630613Recruiting
NOX4 and Related Biomarkers in ADPKD
Role: collaborator
NCT01885559Phase 3Completed
HALT Progression of Polycystic Kidney Disease Study B
Role: collaborator
NCT00283686Phase 3Completed
HALT Progression of Polycystic Kidney Disease Study A
Role: collaborator
NCT00571909Not ApplicableCompleted
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Role: collaborator
All 4 trials loaded